Invenomic Capital Management LP purchased a new position in shares of TriMas Co. (NASDAQ:TRS - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 143,152 shares of the industrial products company's stock, valued at approximately $3,655,000. Invenomic Capital Management LP owned approximately 0.35% of TriMas as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in TRS. Price T Rowe Associates Inc. MD increased its position in shares of TriMas by 6.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 23,870 shares of the industrial products company's stock valued at $639,000 after acquiring an additional 1,478 shares during the last quarter. Diversified Trust Co raised its stake in shares of TriMas by 5.0% during the 2nd quarter. Diversified Trust Co now owns 22,719 shares of the industrial products company's stock worth $581,000 after purchasing an additional 1,072 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of TriMas by 8.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 262,294 shares of the industrial products company's stock valued at $6,704,000 after buying an additional 19,849 shares during the last quarter. Innealta Capital LLC bought a new position in shares of TriMas in the second quarter valued at $26,000. Finally, Rhumbline Advisers increased its holdings in TriMas by 1.4% during the second quarter. Rhumbline Advisers now owns 69,328 shares of the industrial products company's stock worth $1,772,000 after buying an additional 985 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research analysts have recently weighed in on TRS shares. StockNews.com upgraded shares of TriMas from a "sell" rating to a "hold" rating in a research note on Wednesday, November 13th. BWS Financial reissued a "buy" rating and set a $40.00 price target on shares of TriMas in a research report on Tuesday, November 5th.
View Our Latest Analysis on TriMas
TriMas Stock Performance
TRS traded down $0.08 during trading hours on Wednesday, reaching $26.49. The company's stock had a trading volume of 23,589 shares, compared to its average volume of 266,259. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The company's 50-day moving average is $26.48 and its 200-day moving average is $25.82. TriMas Co. has a 52 week low of $22.45 and a 52 week high of $28.51. The firm has a market cap of $1.07 billion, a PE ratio of 41.52 and a beta of 0.66.
TriMas (NASDAQ:TRS - Get Free Report) last posted its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). The company had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The business's quarterly revenue was down 2.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.57 EPS. On average, equities analysts forecast that TriMas Co. will post 1.69 EPS for the current year.
TriMas Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date was Tuesday, November 5th. TriMas's dividend payout ratio is 25.00%.
TriMas Company Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.